Expanded Use of LAP-BAND® for Obese Adults is Approved by FDA

On February 16, 2011, Allergan, Inc. announced that the United States Food and Drug Administration (FDA) approved the LAP-BAND ® System for use on a wider range of adults, including those whose Body Mass Index or BMI fell between 30 and 40 and had at least 1 weight-related health condition.According to Allergan’s Vice President of Clinical Research and Development Frederick Beddingfield, M.D., “Given the proven and significant health ramifications of obesity, we are pleased with the FDA’s decision to expand the use of the LAP-BAND® System.”Obesity is second